The timing of administration of a clinically relevant dose of losartan influences the healing process after contusion induced muscle injury

Journal of Applied Physiology

Volumn 114, Issue 2, 2013, Pages 262-273

  Kobayashi, Tetsuo ^a   Uehara, Kenji ^c   Ota, Shusuke ^a,b   Tobita, Kimimasa ^b   Ambrosio, Fabrisia ^b   Cummins, James H ^a   Terada, Satoshi ^a,b   Fu, Freddie H ^b   Huard, Johnny ^a,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872303140     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00140.2011     Document Type: Article

References (47)

1. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, Patel K. Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev Biol 270: 19-30, 2004.
2. Bedair HS, Karthikeyan T, Quintero A, Li Y, Huard J. Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle. Am J Sports Med 36: 1548-1554, 2008.
3. Chan YS, Li Y, Foster W, Horaguchi T, Somogyi G, Fu FH, Huard J. Antifibrotic effects of suramin in injured skeletal muscle after laceration. J Appl Physiol 95: 771-780, 2003.
4. Crisco JJ, Jokl P, Heinen GT, Connell MD, Panjabi MM. A muscle contusion injury model. Biomechanics, physiology, and histology. Am J Sports Med 22: 702-710, 1994.
5. Criswell TL, Corona BT, Ward CL, Miller M, Patel M, Wang Z, Christ GJ, Soker S. Compression-induced muscle injury in rats that mimics compartment syndrome in humans. Am J Pathol 180: 787-797, 2012.
6. Diaz JA, Fischer DA, Rettig AC, Davis TJ, Shelbourne KD. Severe quadriceps muscle contusions in athletes. A report of three cases. Am J Sports Med 31: 289-293, 2003.
7. Foster W, Li Y, Usas A, Somogyi G, Huard J. Gamma interferon as an antifibrosis agent in skeletal muscle. J Orthop Res 21: 798-804, 2003.
8. Fukushima K, Badlani N, Usas A, Riano F, Fu F, Huard J. The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 29: 394-402, 2001.
9. Gilson H, Schakman O, Kalista S, Lause P, Tsuchida K, Thissen JP. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab 297: E157-E164, 2009.
10. Goto K, Honda M, Kobayashi T, Uehara K, Kojima A, Akema T, Sugiura T, Yamada S, Ohira Y, Yoshioka T. Heat stress facilitates the recovery of atrophied soleus muscle in rat. Jpn J Physiol 54: 285-293, 2004.
11. Goto K, Okuyama R, Sugiyama H, Honda M, Kobayashi T, Uehara K, Akema T, Sugiura T, Yamada S, Ohira Y, Yoshioka T. Effects of heat stress and mechanical stretch on protein expression in cultured skeletal muscle cells. Pflügers Arch 447: 247-253, 2003.
12. Gremmler B, Kunert M, Schleiting H, Ulbricht LJ. Improvement of cardiac output in patients with severe heart failure by use of ACEinhibitors combined with the AT1-Antagonist eprosartan. Eur J Heart Fail 2: 183-187, 2000.
13. Haidet AM, Rizo L, Handy C, Umapathi P, Eagle A, Shilling C, Boue D, Martin PT, Sahenk Z, Mendell JR, Kaspar BK. Long-Term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA 105: 4318-4322, 2008.
14. Huard J, Li Y, Fu FH. Muscle injuries and repair: current trends in research. J Bone Joint Surg Am 84-A: 822-832, 2002.
15. Hurme T, Kalimo H. Activation of myogenic precursor cells after muscle injury. Med Sci Sports Exerc 24: 197-205, 1992.
16. Karalaki M, Fili S, Philippou A, Koutsilieris M. Muscle regeneration: cellular and molecular events. In Vivo 23: 779-796, 2009.
17. Kasemkijwattana C, Menetrey J, Somogyl G, Moreland MS, Fu FH, Buranapanitkit B, Watkins SC, Huard J. Development of approaches to improve the healing following muscle contusion. Cell Transplant 7: 585-598, 1998.
18. Kirk S, Oldham J, Kambadur R, Sharma M, Dobbie P, Bass J. Myostatin regulation during skeletal muscle regeneration. J Cell Physiol 184: 356-363, 2000.
19. Kobayashi T, Goto K, Kojima A, Akema T, Uehara K, Aoki H, Sugiura T, Ohira Y, Yoshioka T. Possible role of calcineurin in heatingrelated increase of rat muscle mass. Biochem Biophys Res Commun 331: 1301-1309, 2005.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
21. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277: 49831-49840, 2002.
22. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98: 9306-9311, 2001.
23. Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 161: 895-907, 2002.
24. Li Y, Negishi S, Sakamoto M, Usas A, Huard J. The use of relaxin improves healing in injured muscle. Ann NY Acad Sci 1041: 395-397, 2005.
25. Li ZB, Kollias HD, Wagner KR. Myostatin directly regulates skeletal muscle fibrosis. J Biol Chem 283: 19371-19378, 2008.
26. McCormick KM, Schultz E. Role of satellite cells in altering myosin expression during avian skeletal muscle hypertrophy. Dev Dyn 199: 52-63, 1994.
27. McCroskery S, Thomas M, Platt L, Hennebry A, Nishimura T, McLeay L, Sharma M, Kambadur R. Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice. J Cell Sci 118: 3531-3541, 2005.
28. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387: 83-90, 1997.
29. Mendias CL, Bakhurin KI, Faulkner JA. Tendons of myostatin-deficient mice are small, brittle, and hypocellular. Proc Natl Acad Sci USA 105: 388-393, 2008.
30. Menetrey J, Kasemkijwattana C, Fu FH, Moreland MS, Huard J. Suturing versus immobilization of a muscle laceration. A morphological and functional study in a mouse model. Am J Sports Med 27: 222-229, 1999.
31. Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin II and renal fibrosis. Hypertension 38: 635-638, 2001.
32. Negishi S, Li Y, Usas A, Fu FH, Huard J. The effect of relaxin treatment on skeletal muscle injuries. Am J Sports Med 33: 1816-1824, 2005.
33. Nozaki M, Li Y, Zhu J, Ambrosio F, Uehara K, Fu FH, Huard J. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am J Sports Med 36: 2354-2362, 2008.
34. Patel K. Follistatin. Int J Biochem Cell Biol 30: 1087-1093, 1998.
35. Petersen MC, Greene AS. Angiotensin II is a critical mediator of prazosin-induced angiogenesis in skeletal muscle. Microcirculation 14: 583-591, 2007.
36. Rodino-Klapac LR, Haidet AM, Kota J, Handy C, Kaspar BK, Mendell Jr. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 39: 283-296, 2009.
37. Rossi CA, Flaibani M, Blaauw B, Pozzobon M, Figallo E, Reggiani C, Vitiello L, Elvassore N, De Coppi P. In vivo tissue engineering of functional skeletal muscle by freshly isolated satellite cells embedded in a photopolymerizable hydrogel. FASEB J 25: 2296-2304, 2011.
38. Sasaki M, Uehara S, Ohta H, Taguchi K, Kemi M, Nishikibe M, Matsumoto H. Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice. Life Sci 75: 869-880, 2004.
39. Schultz E, McCormick KM. Skeletal muscle satellite cells. Rev Physiol Biochem Pharmacol 123: 213-257, 1994.
40. Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, Fowke PJ, Bass JJ. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 180: 1-9, 1999.
41. Tamhane AC, Hochberg Y, Dunnett CW. Multiple test procedures for dose finding. Biometrics 52: 21-37, 1996.
42. Tharaux PL, Chatziantoniou C, Fakhouri F, Dussaule JC. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension 36: 330-336, 2000.
43. Uehara K, Goto K, Kobayashi T, Kojima A, Akema T, Sugiura T, Yamada S, Ohira Y, Yoshioka T, Aoki H. Heat-stress enhances proliferative potential in rat soleus muscle. Jpn J Physiol 54: 263-271, 2004.
44. Wagner KR, Liu X, Chang X, Allen RE. Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 102: 2519-2524, 2005.
45. Wang BW, Chang H, Kuan P, Shyu KG. Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway. J Endocrinol 197: 85-93, 2008.
46. Williams DA. A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 27: 103-117, 1971.
47. Zhu X, Topouzis S, Liang LF, Stotish RL. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 26: 262-272, 2004.